Providence researcher in the news: a promising treatment for kidney disease

Over 100 leaders, researchers and others from Montana and the Pacific Northwest recently convened for the announcement of a pioneering rural health collaborative from Providence and the University of

Two recently published studies of Providence’s Geno4Me program highlight how our whole genome sequencing research is advancing the promise of genomic medicine for all.

Providence and the University of Montana are launching RESOLVE, a pioneering rural health collaborative to improve access and outcomes in rural and indigenous health care.

Lupus, Neurology and Providence Swedish Cancer Institute teams working with our global partners, treated our 100th unique cell therapy research patient this fall. Learn more.

Celebrating World Cancer Day with a look at the work of Carlo Bifulco, M.D. as he helps lead advancements in AI-driven, accessible precision oncology at Providence Cancer Institute.

Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.

Providence and Microsoft Research have developed an AI framework that could revolutionize clinical trials and bring new treatments into play quicker than before.

New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

The award will help Providence Swedish researchers tackle one of the most pressing challenges in cancer care: matching the right patient to the right immunotherapy. Learn more.

Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

In a paper published in the prestigious New England Journal of Medicine AI, researchers from Providence and Microsoft propose an AI framework that could accelerate biomedical discovery.

Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.

Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.

In a new study led by the Providence Swedish Cancer Institute’s Kelly Paulson, M.D., Ph.D., survival rates more than doubled for a group treated with a novel, two-drug combination. Learn more.

A recently published Providence Research Network study found that patient-provider communication, unmet social needs, and other factors can influence whether patients adhere to their ASCVD treatments.

An interview with Providence researchers for the news website Healthcare Intelligence looks at findings from a recent study on the impact of an AI solution on provider documentation burden and burnout

When metastatic breast cancer rocked Renee Leaf's world, she found strength in her life's treasures and a Providence Swedish care team determined to save her life. Watch the video and learn more.

A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.